HSP90AA1 and breast cancer: In contrast, HSP-90 expression in cancer tissues and the presence of autoantibodies to HSP-90 have been associated with poor prognosis in breast cancer [33], while it was found to be of no prognostic value in ovarian and oral carcinomas [25,34,35].